PAVmed Inc. (PAVM)

Market Cap	10.02M
Revenue (ttm)	29,000
Net Income (ttm)	-596,000
Shares Out	27.64M
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	153,385
Open	0.3404
Previous Close	0.3337
Day's Range	0.3400 - 0.3699
52-Week Range	0.3040 - 1.2500
Beta	1.09
Analysts	Strong Buy
Price Target	20.00 (+5,414.2%)
Earnings Date	Nov 13, 2025

About PAVM

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company’s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, incl...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 28, 2016
• Employees: 39
• Stock Exchange: NASDAQ
• Ticker Symbol: PAVM
• Website: https://www.pavmed.com

Analyst Summary

According to one analyst, the rating for PAVM stock is "Strong Buy" and the 12-month stock price target is $20.0.

Price Target

$20.0

(5,414.20% upside)

Analyst Consensus: Strong Buy